• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
VIT
Click for more information
0.00% 7.2¢

VITURA HEALTH LIMITED - News & Media

Market Cap $41.46M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Vitura Health Limited is a diversified digital health company that operates various... Vitura Health Limited is a diversified digital health company that operates various businesses via its subsidiaries CanView, Doctors on Demand, Cortexa, CDA Clinics, Cannadoc, BHC and Adaya. It consists of Medical segment involving the sale and distribution of medicinal cannabis products; Clinics segment involving the operation of medicinal cannabis clinics, and Consumer segment involving the sale of consumer (non-medical) products in both Australia and Asia. Burleigh Heads Cannabis operates the prescriber, patient, pharmacy and supplier online platform, CanView, which sells and distributes 350+ therapeutic products and device stock-keeping units (SKUs) within Australia from medicinal cannabis producers. It also owns Doctors on Demand Pty Ltd, a telehealth platform business that provides primary health solutions. It owns 75.5% Cannadoc Health Pty Ltd, a medicinal cannabis clinic business that undertakes telehealth consultations with patients seeking access to medicinal cannabis.More

Articles & Videos

Vitura joint venture prescribes shrooms for therapeutic use in Australian-first

In an Australian-first pharmaceutical achievement, Vitura Health Limited has announced the first ever shipment of 'shrooms' into Oz.

18 Mar 2024 12:00 (AEDT)

Canberra is making vapes prescription-only and Vitura Health is going to provide them

Quickly responding to Canberra's new laws that kicked off this month banning non-prescription vapes, ASX healthcare stock Vitura (ASX:VIT) has spied a "market opportunity".

09 Jan 2024 15:15 (AEDT)

Vitura Health (ASX:VIT) enters into Psychedelic joint venture "Cortexa" with PharmAla Biotech

Vitura Health (ASX:VIT) and Canada-based PharmAla Biotech have established a 50:50 joint venture called Cortexa, which aims to become a leading supplier of psychedelics for research and therapeutic use in Australia.

02 May 2023 13:51 (AEST)



(20min delay)
Last
7.2¢ 		Change
0.000(0.00%) 		Mkt cap ! $41.46M
Open High Low Value Volume
7.2¢ 7.2¢ 6.9¢ $40.9K 591.6K

Buyers (Bids)

No. Vol. Price($)
1 9000 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 153567 2
View Market Depth
Last trade - 16.10pm 23/08/2024 (20 minute delay) ?
Last
6.9¢ 		  Change
0.000 ( 1.43 %)
Open High Low Volume
7.0¢ 7.0¢ 6.9¢ 46093
Last updated 14.47pm 23/08/2024 ?
VIT (ASX) Chart

Top Stories

Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back

This week’s biggest story (in my view) for the Australian economy actually started late last week. Quietly, CBA cut its term deposit interest rates, prompting ANZ and NAB to do the same on Monday of this week.
Dale Gillham's weekly wrap: responding to a weak iron ore price with investing decisions Given the recent fall in iron ore prices below the $100 mark, now might be the time to buy into specialised stocks in the materials sector.
The business of sport: Warren Tredrea's take on this week's news Former Port Adelaide AFL star – turned media personality – Warren Tredrea and co-host Jack Hudson explore money in sport.
How flooding did Strategic Energy Resources a favour: Four holes down in 'redesigned' gold & copper campaign Strategic Energy Resources is 4 holes into a 40-hole RC drill campaign at its Achilles 1 copper-gold target in the Cobar Basin of NSW.
Reporting wrap: Inghams, Accent, Mayne Pharma Inghams Group Ltd, Accent Group Ltd and Mayne Pharma Group Ltd all reported final year results for the 2024 fiscal year.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.